Anxiolytic-like effect of ethanolic extract of Argemone mexicana and its alkaloids in Wistar rats

سال انتشار: 1395
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 270

فایل این مقاله در 13 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_AJP-6-4_013

تاریخ نمایه سازی: 1 مهر 1398

چکیده مقاله:

Objective: Argemone mexicana is a Papaveracea plant; some reports have shown their antibacterial, anti-cancer, sedative and probably anti-anxiety properties. From their aerial parts, flavonoids and alkaloids have been isolated, which are intrinsically related to some actions on the central nervous system. The aim of this study was to evaluate the anxiolytic-like effects of the plant, using its ethanolic extract and alkaloid-enriched extract obtained from fresh leaves. Material and Methods: Phytochemical screening was carried out together with evaluation of antioxidant capacity and the enrichment of alkaloids present in the extract. Subsequently, 100 and 200 mg/kg doses of ethanolic extract and alkaloid-enriched extract (200 µg/kg) were intraperitoneally administered to female Wistar rats, which were exposed to elevated plus maze (EPM) test. Picrotoxin (1 mg/kg), a non-competitive gamma-aminobutyric acid A (GABAA) chloride channel antagonist, was used in experimental procedures to evaluate if this receptor is involved in the anxiolytic-like effects of A. mexicana. To discard motor effects associated with the treatments, the rats were evaluated by the locomotor activity test. Results: Only the ethanolic extract at 200 mg/kg and alkaloid-enriched extract (200 µg/kg) produced anxiolytic-like effects similarly to diazepam 2 mg/kg on EPM test, without affecting locomotor activity. Meanwhile, the administration of picrotoxin blocked anti-anxiety effect of alkaloid-enriched extract of the plant. Conclusion: These results showed that A. mexicana is a potential anxiolytic agent and we suggest that this effect is mediated by the GABAA receptor. These effects are related to the presence of alkaloids.

نویسندگان

Aideé Itzel Arcos-Martínez

Institute of Neuroethology, University of Veracruz (UV), Xalapa-Veracruz, Mexico

Omar David Muñoz-Muñiz

Support Services Unit in Analytical Resolution (SARA), University of Veracruz (UV), Xalapa-Veracruz, Mexico

Miguel Ángel Domínguez-Ortiz

Institute of Basic Sciences (ICB), University of Veracruz (UV), Xalapa-Veracruz, Mexico

Margarita Virginia Saavedra-Vélez

Institute of Neuroethology, University of Veracruz (UV), Xalapa-Veracruz, Mexico

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Anarthe S, Chaudhari S. 2011. Neuropharmacological study of Argemone mexicana ...
  • Benzie IF, Strain JJ. 1996. The ferric reducing ability of ...
  • Bhalke R, Gosavi S. 2009a. Anti-stress and antiallergic effect of ...
  • Bhalke R, Mandole Y, Mali N. 2009b. Phytochemical investigation and ...
  • Bhattacharjee I, Chatterjee S, Chatterjee S, Chandra G. 2006. Antibacterial ...
  • Brahmachari G, Gorai D, Roy R. 2013. Argemone mexicana: chemical ...
  • Carro-Juárez M, Rodríguez-Landa J, Rodríguez-Peña M de L, Rovirosa-Hernández M ...
  • Chang C, Yang M, Wen H, Chern J. 2002. Estimation ...
  • Cohen H, Matar M, Joseph Z. 2013. Animal models of ...
  • Contreras CM, Martínez-Mota L, Saavedra M. 1998. Desipramine restricts estral ...
  • Contreras CM, Rodríguez-Landa JF, García-Ríos RI, Cueto-Escobedo J, Guillen-Ruiz G, ...
  • Dash GK, Murthy PN. 2011. Evaluation of Argemone mexicana Linn. ...
  • Deng S, West BJ, Palu AK, Zhou BN, Jensen CJ. ...
  • Estrada-Camarena E, Contreras CM, Saavedra M, Luna-Baltazar I, López-Rubalcava C. ...
  • Fedotova J. 2012. Effects of stimulation and blockade of D2 ...
  • Fernández-Guasti A, Ferreira A, Picazo O. 2001. Diazepam, but not ...
  • File SE, Gonzalez LE, Gallant R. 1999. Role of the ...
  • Furlan SM, Brandão ML. 2001. Effects of systemic injections of ...
  • Gee KW, Bolger MB, Brinton RE, Coirini H, McEwen BS. ...
  • Gilhotra N, Dhingra D. 2010.GABAergic and nitriergic modulation by curcumin ...
  • Girish C, Raj V, Arya J, Balakrishnan S. 2013. Involvement ...
  • Graz B, Willcox ML, Diakite C, Falquet J, Dackuo F, ...
  • Gutiérrez-García AG, Contreras CM. 2009. Stressors can affect immobility time ...
  • Hakim SAE. 1954. Argemone oil, sanguinarine, and epidemic-dropsy glaucoma. Br ...
  • Hogg S. 1996. A review of the validity and variability ...
  • House A, Stark D. 2002. Anxiety in medical patients. Brit ...
  • Hovatta I, Juhila J, Donner J. 2010. Oxidative stress in ...
  • Ji G, Shukla SK, Dwivedi P, Sundaram S, Prakash R. ...
  • Kanadaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, ...
  • Kardos J, Blasko G, Simonyi M. 1986. Enhancement of gamma-aminobutyric ...
  • Kaufman PB, Hoyt JE, Bergman S, Madsen BJ, Perry M, ...
  • Kennedy DO, Wightman EL. 2011. Herbal extracts and phytochemicals: plant ...
  • Martínez-Mota L, Estrada-Camarena E, López-Rubalcava C, Contreras CM, Fernández-Guasti A. ...
  • Miliauskas G, Venskutonis PR, van Beek TA. 2004. Screening of ...
  • National Research Council. 2011. Committee for the update of the ...
  • Navarro MC, Crespo ME, Montilla MP. 2008. Otras plantas para ...
  • Nijveldt RJ, Nood E, Hoorn DE, Boelens PG, Norren K, ...
  • NOM-062-ZOO-1999 (Norma Oficial Mexicana- 062-ZOO- 1999). Especificaciones técnicas para la ...
  • Olson ME, Bruce J. 1986. Ovariectomy, ovariohysterectomy and orchidectomy in ...
  • Pellow S, Chopin P, File SE, Briley M. 1985. Validation ...
  • Perumal P, Sekar V, Rajesh V, Gandhimathi S, Sampathkumar R, ...
  • Priya CL, Rao KV. 2012. Ethnobotanical and current ethanopharmacological aspects ...
  • Rahman S, Salehin F, Mostofa-Jamal AH, Parvin A, Alam K. ...
  • Ramos A, Pereira E, Martins GC, Wehrmeister TD, Izidio GS. ...
  • Ro JS, Lee SS, Lee KS, Lee MK. 2001. Inhibition ...
  • Rodríguez-Landa JF, García-Ríos RI, Cueto-Escobedo J, Bernal-Morales B, Contreras CM. ...
  • Rodríguez-Landa JF, Vicente-Serna J, Rodríguez-Blanco LA, Rovirosa-Hernández M de J, ...
  • Sanders SK, Shekhar A. 1995. Regulation of anxiety by GABAA ...
  • Scherer R, Godoy HT. 2009. Antioxidant activity index (AAI) by ...
  • Schwarzbach AE, Kadereit JW. 1999. Phylogeny of prickly poppies, Argemone ...
  • Singh S, Pandey VB, Singh TD. 2011. Alkaloids and flavonoids ...
  • Spanos GA, Wrolstad RE. 1990. Influence of processing and storage ...
  • Uusi-Oukari M, Korpi ER. 2010. Regulation of GABAA receptor subunit ...
  • Wada T, Fukuda N. 1991. Effects of DN-2327, a new ...
  • Walf AA, Frye CA. 2007. The use of the elevated ...
  • Walf AA, Frye CA. 2008. Parity and estrogen-administration alter affective ...
  • Wink M. 2000. Interference of alkaloids with neuroreceptors and ion ...
  • Xu LF, Chu WJ, Qing XY, Li S, Wang XS, ...
  • Zorumski CF, Paul SM, Izumi Y, Covey DF, Mennerick S. ...
  • نمایش کامل مراجع